Project challenge: Identication of suitable chiral reagent for chemical resolution, process validation, desired polymorph. Solution design: Often API development is bound by IP constraints. In order to develop a scalable and robust process to address IP challenges, the following approach was adopted by the CPS team. Non-infringing route to circumvent IP barrier was proposed Screening of chiral resolving agents and solvents to yield the maximum eciency in terms of yield and highest desired enantiomer
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market